NCT06817330 The Effect of a Music Intervention on Postictal Agitation in Electroconvulsive Therapy Patients
| NCT ID | NCT06817330 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Erasmus Medical Center |
| Condition | Music Intervention |
| Study Type | INTERVENTIONAL |
| Enrollment | 92 participants |
| Start Date | 2025-11-25 |
| Primary Completion | 2027-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 92 participants in total. It began in 2025-11-25 with a primary completion date of 2027-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will investigate the effect of music on postictal agitation when played peri-interventionally for patients undergoing electroconvulsive therapy for severe depression.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing ECT treatment for depression (including depression as part of bipolar disorder) * Adult patients (≥18 years) * Hypnotic agent used is etomidate * Sufficient understanding of the Dutch language (in judgement of the attending physician or researcher) * Written informed consent by patient or legal representative Exclusion Criteria: * Significant impaired hearing (defined as unable to communicate verbally or listen to music) * Severe neurological condition (defined as interfering with the ability to process music) * Patients receiving ECT for treatment of schizophrenic disorders
Contact & Investigator
Markus Klimek, MD, PhD
PRINCIPAL INVESTIGATOR
Erasmus Medical Center
Frequently Asked Questions
Who can join the NCT06817330 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Music Intervention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06817330 currently recruiting?
Yes, NCT06817330 is actively recruiting participants. Contact the research team at e.vandervalkbouman@erasmusmc.nl for enrollment information.
Where is the NCT06817330 trial being conducted?
This trial is being conducted at Rotterdam, Netherlands, Rotterdam, Netherlands.
Who is sponsoring the NCT06817330 clinical trial?
NCT06817330 is sponsored by Erasmus Medical Center. The principal investigator is Markus Klimek, MD, PhD at Erasmus Medical Center. The trial plans to enroll 92 participants.